Schedule 13G ownership disclosure

CLARUS THERAPEUTICS HXXXBANKRUPTCY EFF 030123

Security class unavailable · CUSIP: 18271L107

Event date: 2022-07-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,461,822
Percent of class
2.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-077678
Form type
SC 13G/A
Filer
Bracebridge Capital, LLC
CIK
CIK 1426486
Filed
Jul 06, 2022
Reporting period
Jul 06, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub